Frontlight ResearchEarly access
Trial site
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
- 7running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer7 trials
- Cervical cancer2 trials
- Kidney cancer2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Neuroendocrine tumours1 trial
- and 2 more
- Phase
- Phase 24 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5 trials
- Nanobiotix1 trial
- NextPoint Therapeutics, Inc.1 trial
- Noah Hahn, M.D.1 trial
Running trials
Not yet recruiting
Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC)
Recruiting
Recruiting
Recruiting
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Active, not recruiting
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer3 recruiting
- Neuroendocrine tumours1 recruiting
- Prostate cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026